Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Common Name: Drug-induced gout, unspecified shoulder
- Technical Term: Drug-induced gout, unspecified shoulder
Summary
Drug-induced gout is a form of inflammatory arthritis caused by medications that elevate uric acid levels, leading to urate crystal deposition in joints. This results in acute inflammation and pain, specifically affecting the shoulder joint in this case.
Causes
This condition arises from medications that increase uric acid production or reduce its excretion. Common triggers include diuretics, immunosuppressants, low-dose aspirin, and certain chemotherapy agents. The elevated uric acid promotes crystal formation in synovial fluid, triggering an inflammatory response in the shoulder joint.
Risk Factors
- Use of medications known to raise uric acid levels
- Pre-existing hyperuricemia or gout history
- Renal impairment (reduced uric acid excretion)
- Dehydration or high-purine diets (exacerbating uric acid buildup)
Symptoms
- Sudden, severe shoulder pain (often nocturnal)
- Swelling, redness, and warmth in the shoulder joint
- Limited range of motion in the shoulder
- Tenderness to touch
- Fever (in severe cases)
Diagnosis
Diagnosis involves a physical exam of the inflamed shoulder joint, blood tests for uric acid levels, and joint fluid analysis to detect urate crystals. Imaging (e.g., X-rays, ultrasound) may assess joint damage, while medication history confirms the drug-induced etiology.
Treatment Options
Treatment focuses on managing acute symptoms and addressing the underlying cause. Nonsteroidal anti-inflammatory drugs (NSAIDs) or colchicine may reduce inflammation and pain. Corticosteroids can be used for severe cases. Adjusting or discontinuing the causative medication is often necessary. Long-term management may include uric acid-lowering agents if hyperuricemia persists.
Prognosis and Follow-Up
With appropriate treatment, symptoms typically improve within days to weeks. However, recurrent episodes may occur if the causative medication is not discontinued or if underlying risk factors persist. Regular follow-up is recommended to monitor uric acid levels and joint function, especially if the triggering drug cannot be avoided.
Complications
Untreated or recurrent episodes can lead to chronic joint damage, including tophi (urate crystal deposits) or persistent joint deformity. Chronic inflammation may also increase the risk of secondary osteoarthritis in the shoulder.
Lifestyle & Prevention
- Avoid or limit use of medications known to raise uric acid levels when possible.
- Maintain adequate hydration to support uric acid excretion.
- Follow a low-purine diet to reduce uric acid production.
- Monitor uric acid levels regularly if taking high-risk medications.
When to Seek Professional Help
Seek medical attention if you experience sudden, severe shoulder pain, swelling, or redness, especially if you are taking medications known to affect uric acid levels. Prompt evaluation is important to confirm the diagnosis and initiate treatment to prevent complications.
Tips for Medical Coders
Document the specific shoulder involvement (unspecified) and confirm the drug-induced etiology. Ensure the medical record supports the absence of bilateral or right/left specification for the shoulder. Code M10.219 is appropriate when the shoulder is affected but not further specified as right or left.
M10.219 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.